scispace - formally typeset
A

Ana Luisa Neves

Researcher at Imperial College London

Publications -  94
Citations -  3346

Ana Luisa Neves is an academic researcher from Imperial College London. The author has contributed to research in topics: Medicine & Health care. The author has an hindex of 18, co-authored 74 publications receiving 2226 citations. Previous affiliations of Ana Luisa Neves include University of Porto & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Impact of the gut microbiota on inflammation, obesity, and metabolic disease.

TL;DR: Current knowledge about the mechanistic interactions between the gut microbiota, host energy metabolism, and the host immune system in the context of obesity and metabolic disease is discussed, with a focus on the importance of the axis that links gut microbes and host metabolic inflammation.
Journal ArticleDOI

The influence of social networking sites on health behavior change: a systematic review and meta-analysis

TL;DR: Overall, SNS interventions appeared to be effective in promoting changes in health-related behaviors, and further research regarding the application of these promising tools is warranted.
Journal ArticleDOI

International variations in primary care physician consultation time: a systematic review of 67 countries.

TL;DR: In this article, a systematic review of published and grey literature in English, Chinese, Japanese, Spanish, Portuguese and Russian languages from 1946 to 2016, for articles reporting on primary care physician consultation length was conducted.

International variations in primary care physician consultation time: a systematic review of 67 countries

TL;DR: There are international variations in consultation length, and it is concerning that a large proportion of the global population have only a few minutes with their primary care physicians, which is likely to adversely affect patient healthcare and physician workload and stress.
Journal ArticleDOI

Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk.

TL;DR: The potential molecular implications of ME on several CV risk factors, such as obesity, insulin resistance, dyslipidemia, and oxidative stress, as well as its potential impact on the development of CV target-organ disease are discussed.